Clinical Trial Update: Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of post-operative TZP-101 (ulimorelin) after partial bowel resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• TZP-101 (ulimorelin) (ulimorelin)

Snippet

Sponsor: Norgine | Conditions: Postoperative Ileus | Phase 3 | Status: COMPLETED